PlainPill

Phosphatidylserine

The short answer. More people than not who report on Phosphatidylserine say it helped (73% of 110). It is most often used for anxiety: 95% of 39 reports say that improved. It is well studied — 14 meta-analyses on PubMed.

What users report
73%helped110 reports · high confidence
80 helped13 mixed17 didn't help

From 334 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
14
meta-analyses
83
RCTs
18,835
papers

What Phosphatidylserine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 14 meta-analyses on PubMed ↗ · 83 randomized trials ↗

J Altern Complement Med · 2021 · Meta-analysis / systematic review
Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis

Conclusion: The effects of phosphatidylserine on overall symptoms of ADHD (ES 0.76; 95% CI: -0.07 to 1.60; p = 0.07) and hyperactivity-impulsivity (ES 0.24; 95% CI: -0.04 to 0.53; p = 0.09) were not statistically significant. Conclusions: Preliminary evidence suggests that phosphatidylserine may be effective for reducing symptoms of inattention in children with ADHD, although the quality of the evidence is low and additional research in this area is warranted.

PubMed 33539192 ↗
PLoS One · 2024 · Meta-analysis / systematic review
Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis

Conclusion: The rankings of safety and efficacy of the 12 antioxidants vary. Due to the low methodological quality of the included studies, the probability ranking cannot fully explain the clinical efficacy, and the results need to be interpreted with caution. More high-quality studies are still needed to verify our findings.

PubMed 38547138 ↗
Thromb Haemost · 2014 · Meta-analysis / systematic review
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review

Conclusion: In conclusion, routine measurement of aPS/PT (but not aPT) might be useful in establishing the thrombotic risk of patients with previous thrombosis and/or systemic lupus erythematosus. Their inclusion as laboratory criteria for the APS should be indisputably further explored.

PubMed 24172938 ↗
Cent Nerv Syst Agents Med Chem · 2023 · Meta-analysis / systematic review
Neuronutrients and Central Nervous System: A Systematic Review

Conclusion: The areas of neurology and psychiatry have shown great advances regarding the deepening of knowledge in prophylaxis and pathophysiology, as well as in the treatment of established diseases. The recognition of the role of nutrition as an adjunct to these processes is currently growing. The search in scientific bases for neuro nutrients reveals a great growth of publications related to this theme. In the present text, some of these nutrients were explored to verify the current state of knowledge.

PubMed 36411563 ↗
Registered clinical trials

50 human trials on ClinicalTrials.gov test Phosphatidylserine — 35 completed, 3 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

20 reports name a product containing Phosphatidylserine (2009–2024); 11 involved hospitalization or worse. Most often reported:

  • Vomiting · 4
  • Mental impairment · 2
  • Cerebrovascular accident · 2
  • Contusion · 2
  • Epistaxis · 2
  • Headache · 2

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

Approved claims in Canada (Health Canada)
  • Helps support cognitive/brain health/function.

Health Canada monograph: Phosphatidylserine ↗

Health claims in the EU (European Commission)

No health claim for Phosphatidylserine is authorised in the EU.

3 proposed claims were rejected, usually because EFSA found the evidence insufficient (example ↗).

US government research funding (NIH)

NIH has funded 32 research projects with Phosphatidylserine in the title, $30,590,918 in total (1991–2026). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

300 mgas reported
400 mgbefore bed
150 mgdaily
300 mgnightly
550 mgas reported
300-500 mgas reported

Reported side effects

How often each side effect came up across all reports.

drowsiness ×2fatigue ×2anhedonia ×1headache ×1hypotension ×1prolonged cold ×1jitteriness ×1stimulation ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“A supplement I have never seen on here that works great for me is Phosphatidylserine. Somehow awesome.”
HelpedRead the discussion ↗
“I have been taking this...and I have had great results...From my research, I found phosphatidylserine to be of little to no benefit on cognitive function.”
MixedRead the discussion ↗
“Phosphatidylserine (8/10): ... it made a pretty big impact as far as stress reduction for me. I felt less physical anxiety in social situations...”
HelpedRead the discussion ↗
“100 - 200mg Phosphatidylserine helps with my insomnia when I drink too much coffee during nightshift.”
HelpedRead the discussion ↗
Read more Phosphatidylserine reviews →
Top discussions (5)

Phosphatidylserine compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate